Innovative Prefilled Injector Significantly Reduces Greenhouse Gas Emissions and Environmental Footprint

A new peer-reviewed study, set to be released on July 30, 2024, compares the environmental footprint of an innovative prefilled injection device to widely used traditional glass syringe options. This groundbreaking research reveals that greenhouse gas emissions can be significantly reduced by the adoption of blow-fill-seal (BFS) manufactured prefilled injectors, which are soon to be available on the market.

The study, authored by Robert Litan, PhD, former Director of Economic Studies at The Brookings Institution, and Matthew Eckelman, PhD, Adjunct Associate Professor at the Yale School of Public Health, delves into the environmental impact of different injection device options. Their expertise in emissions modeling, coupled with the support of engineers and scientists from Kymanox, a global professional services company exclusively serving life sciences, allowed for a comprehensive analysis.

The year-long study revealed a substantial difference in favor of the Prefilled Injector developed by ApiJect Systems across all categories of resource use and environmental impact. The research meticulously quantified the environmental footprint of each step involved in the production and distribution processes of the different types of injection devices.

The results demonstrate that the Prefilled ApiJect Injector boasts a significantly lower environmental footprint compared to traditional options:

* Single-Dose Glass Vial: Impacts are approximately 125% higher per dose.
* Luer-type Prefilled Syringes: Impacts are approximately 100% higher per dose.
* Multi-Dose Vial and Staked-type Prefilled Syringes: Impacts are 65-75% higher per dose.

Furthermore, the study explored water usage during manufacturing, cleaning, and sterilization. It found that a typical single-dose glass vial requires over 100 times more water than the Prefilled ApiJect Injector.

This study provides compelling evidence of the significant environmental benefits associated with transitioning to innovative, prefilled injection devices like the ApiJect Injector. By minimizing resource consumption and reducing greenhouse gas emissions, this technology offers a promising solution for creating a more sustainable healthcare industry.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top